Criterion #,Criterion,Max Score,Satisfaction (%),Score Awarded,Rationale
1,"Reward for accurately documenting the gabapentin taper: 200 mg at bedtime for the next three nights, then discontinue",18,90.0,16.2,"Note states ""200 mg at bedtime for three nights then stop"" which matches taper instructions closely."
2,Reward for including the contingency plan: patient to call if paresthesia returns and may hold at 100 mg instead of stopping completely,7,0.0,0.0,Contingency to call if paresthesia returns or hold at 100 mg was not mentioned.
3,"Reward for correctly recording maintenance medications and related instructions: lisinopril 10 mg in the morning, atorvastatin 40 mg with supper (discard 20 mg leftovers), aspirin 81 mg any time",17,0.0,0.0,"Lisinopril, atorvastatin 40 mg with supper (discard 20 mg), and aspirin 81 mg instructions absent."
4,Reward for noting advice to space turmeric-ginger capsules at least four hours away from aspirin to reduce bleeding risk,6,0.0,0.0,No mention of spacing turmeric-ginger capsules 4 h away from aspirin.
5,Reward for documenting the CBC lab order to be completed before next week’s visit with no fasting required,12,90.0,10.8,"CBC ordered before next week, explicitly notes no fasting required."
6,Reward for capturing the clinician’s plan to send a fresh blister pack of atorvastatin 40 mg,6,0.0,0.0,No plan documented to send a fresh blister pack of atorvastatin 40 mg.
7,"Reward for reflecting patient adherence issues and pill-sorting confusion (e.g., swallowing all pills at once, similarity of aspirin and turmeric, caregiving for wife disrupting routine)",6,0.0,0.0,Patient’s pill-sorting confusion and adherence issues not reflected.
8,"Reward for including the instruction to log bedtime, wake-up time, and any groggy spells in a notebook",6,95.0,5.7,"Instruction to log bedtime, wake-up, and groggy spells captured verbatim."
9,"Penalize for copying medication information from the chart that conflicts with the encounter (e.g., atorvastatin 20 mg, gabapentin 300 mg) or importing unrelated chart data",25,70.0,-7.5,"Aside from referencing the existing 300 mg gabapentin, no conflicting med list or unrelated chart data copied; minor concern only."
10,Reward for overall completeness: note captures at least 80 % of clinically relevant details explicitly or implicitly stated in the transcript,20,30.0,6.0,Captures roughly 3 of 11 key details; overall completeness limited.
11,"Penalize for significant omissions or fabrications that alter the clinical narrative (e.g., missing taper details, adding unspoken diagnoses)",20,25.0,-15.0,"Multiple important omissions (maintenance meds, contingency plan, adherence issues); no fabrications."
